$RITM

Rithm Capital Corp. (RITM): Results of Operations and Financial Condition

Rithm Capital Corp. (RITM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ritm-2026630x8xkxexhibit991.htm EX-99.1 Document Exhibit 99.1 Rithm Capital Corp. Announces Second Quarter 2026 Results NEW YORK, NY - (BUSINESS WIRE) — Rithm Capital Corp. (NYSE: RITM; “Rithm Capital,” “Rithm” or the “Company”) today reported the following information

Original reporting
Published Jul 28, 2026, 10:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RITM
Bullish
medium confidence
Mentioned
$RITM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RITMBullishMed
01

Why it matters

The most actionable elements are the quantified quarterly performance metrics: AUM and inflows, asset management revenue growth, Elecor leasing and refinancing completion, securitization and loan purchase volumes, Newrez operating income and annualized operating ROE, and Genesis origination volume and sponsor growth, alongside GAAP net income and earnings available for distribution per share.

02

Market read

This is a primary earnings release with multiple quantified operating and financial metrics that can drive near-term positioning ahead of the earnings call.

03

What to watch

The release emphasizes non-GAAP and operating ROE excluding MSR MTM losses; traders may need to separately assess GAAP earnings quality and the durability of gross inflows and origination volumes.

Relevance 7/10Novelty 8/10Timing: today’s SEC 8-K earnings release for Q2 2026, before/around the scheduled 8:00 a.m. ET earnings call

Background

Rithm Capital filed an SEC 8-K with Exhibit 99.1 reporting second quarter 2026 results and business highlights across its asset management, commercial real estate (Elecor), investment portfolio securitizations, and mortgage origination/servicing (Newrez) plus residential transitional lending (Genesis).

Company-level read

Ticker impact

$RITMBullishMedium confidence
Context

Rithm reported Q2 2026 results, including GAAP net income of $20.2M, earnings available for distribution of $338.9M, and $61B AUM.

Expected impact

Likely supportive for near-term sentiment given higher AUM, higher asset management revenue, and a 22% annualized operating ROE at Newrez, though the market may focus on sustainability of inflows and credit performance.

Evidence & confidence

This is a primary 8-K earnings release with multiple quantified operating metrics (AUM, inflows, revenue, ROE, leasing, securitizations, and dividend). The direction is inferred from the reported increases (AUM up, asset management revenue up, Genesis record origination volume, Newrez operating ROE up), but the article does not provide guidance or credit-loss details that could swing the stock.

Market effects

Adds datapoints for non-bank mortgage origination/servicing and alternative asset management demand, potentially informing read-across on securitization and origination volumes.

Elecor’s leasing metrics provide incremental signal on Class A office leasing momentum in New York City and San Francisco.

Limited beyond US credit and securitization markets, since the disclosures are company-specific.

Counterpoint

Despite strong operating metrics, investors may discount the headline profitability if underlying credit performance, MSR volatility, or funding costs deteriorate, none of which are detailed here.

Key entities

  • Rithm Capital Corp.

    Company reporting Q2 2026 results, including GAAP net income, earnings available for distribution, dividend, and segment operating metrics.

  • Newrez LLC

    Mortgage origination and servicing platform reporting Q2 2026 pre-tax operating income and 22% annualized operating ROE.

  • Genesis Capital LLC

    Residential transitional lending platform reporting Q2 2026 origination volume and sponsor base expansion.

  • Elecor

    Owner and operator of Class A office properties reporting leasing momentum and a $283M refinancing close.

  • Upgrade, Inc.

    Counterparty under an existing forward flow agreement for home improvement loan purchases.

Related articles

$RITMMed

Why is Rithm Property Trust stock surging today? By Investing.com

Investing.com reports Rithm Property Trust (RITM) shares rose 14% in pre-open after investors reassessed its planned $300 million public equity offering and $200 million private placement with an affiliate of Rithm Capital. Proceeds fund a Genesis affiliates multifamily transition loan portfolio with about $951.1 million unpaid principal balance. Preliminary Q2 2026 results showed GAAP comprehensive income and book value near $30.30; analysts’ 12-month target is $22.

$RKTMed

Rocket, Fannie and Freddie downgraded to neutral by BTIG

BTIG downgraded Rocket, Fannie Mae and Freddie Mac to neutral from buy in Doug Harter’s second-half outlook, citing a tougher-than-expected rate environment and reduced visibility on “normalized” earnings. For Fannie/Freddie, BTIG said uncertainty around conservatorship timing limits near-term upside; it valued Fannie at $26 and Freddie at $32 in a positive case, but $4 each if preferreds convert to common. BTIG kept UWM at buy but cut its price target to $4 from $10 amid leverage/dividend conce

$CRGOMedAI 8/10

Why is Freightos stock soaring today?

Freightos (CRGO) shares rose about 11.5% after the freight booking and payments platform reported Q2 revenue of $7.7M versus LSEG-estimated $7.3M. The company posted a narrower loss of 3 cents per share. It reported record gross booking value of $422M (+33% YoY) and trimmed its full-year revenue outlook to $30.4M-$31.0M.

$AKAMMed

Is Wall Street Bullish or Bearish on Akamai Technologies Stock?

Akamai Technologies (AKAM) has risen sharply, up 68.3% over the past year and 43.1% YTD, with a market cap around $17.96B. After fiscal 2026 Q2 results on Aug. 6, shares fell nearly 3% then over 6% as GAAP operating margin dropped to 7.3% from 14.5% and guidance missed. Revenue rose 5.4% to $1.1B. Analysts rate AKAM “Moderate Buy” (22 firms), with HSBC cutting its target to $123 from $171.

$LONAMed

LeonaBio beats Q2 loss forecast as Phase 3 ELAINE-3 trial advances

LeonaBio (NASDAQ:LONA) reported a Q2 loss of $0.80 per share, smaller than analysts’ $1.12 forecast. Net loss rose to $19.0 million from $7.0 million a year earlier. Phase 3 ELAINE-3 enrollment nears 600 target, with 495 patients enrolled and topline results expected in H2 2027. Cash fell to $51.1 million from $88.3 million.